Tag: Shivang

Govt watchdog many gaps in FDAs oversight of drug safety

Gov’t watchdog: many gaps in FDA’s oversight of drug safety by The Associated Press Posted Jan 14, 2016 10:12 am MDT Last Updated Jan 14, 2016 at 11:21 am MDT AddThis Sharing ButtonsShare to TwitterTwitterShare to FacebookFacebookShare to RedditRedditShare to 電子郵件Email WASHINGTON – The Food and Drug Administration is working hard to speed up reviews of new drugs, yet often fails to keep track of safety issues with those medicines once they reach patients, according to government investigators.A new Government Accountability Office report outlines a host of shortcomings in FDA’s system for tracking drug safety, including incomplete, outdated and inaccurate information.The new findings are significant because FDA leadership have stressed the speed and efficiency with which agency scientists approve experimental drugs. Last year the agency approved 45 first-of-a-kind drugs, the highest number in 19 years. More than half received some form of specialized review to speed or streamline their review.But the GAO says the agency often fails to keep track the follow-up studies required for these high-priority drugs. read more

Read More Govt watchdog many gaps in FDAs oversight of drug safety